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RESUMEN
Interacciones dieta-genotipo entre el consumo de
grasas y polimorfismos comunes determinando el me-
tabolismo lipídico.
Las recomendaciones dietéticas actuales referentes al
consumo de grasas en la dieta han sido realizadas sin tener
en cuenta las posibles diferencias genéticas de las personas
que podrían ser las responsables de las diferentes respues-
tas interindividuales que frecuentemente se observan ante
la misma dieta. La presencia de variabilidad genética ha si-
do puesta de manifiesto para todos los genes relacionados
con el metabolismo lipídico, por lo que existe un ingente nú-
mero de genes y de variantes genéticas para ser incluidas
en los estudios sobre interacciones dieta-genotipo en el ám-
bito específico del consumo de grasas y aceites. Se revisa-
rán algunos ejemplos sobre interacciones grasa-genotipo.
Estas interacciones incluyen: la interacción entre el consumo
de grasa total y el polimorfismo 514C/T en el promotor del
gen de la lipasa hepática determinando las concentraciones
de colesterol ligado a lipoproteínas de alta densidad (c-
HDL); la interacción entre el consumo de ácidos grasos po-
liinsaturados y el polimorfismo 75G/A en el promotor del
gen APOA1 en las concentraciones plasmáticas de c-HDL;
la interacción entre los ácidos grasos poliinsaturados y el po-
limorfismo L162V en el gen PPARA determinando las con-
centraciones plasmáticas de triglicéridos y de apolipoproteí-
na C-III; la interacción entre el polimorfismo 1131TC en
el promotor del gen de la APOA5 determinando el metabo-
lismo de los triglicéridos. Aunque se han publicado cientos
de estudios dieta-genotipo en el ámbito del metabolismo li-
pídico, el nivel de evidencia científica todavía es bajo para
realizar recomendaciones nutricionales a la población, por lo
que se requiere mucha más investigación nutrigenética.
PALABRAS CLAVE: Dieta – Genes – Interacción – Lípi-
dos – Nutrigenética – Polimorfismos.
SUMMARY
Diet-gene interactions between dietary fat intake
and common polymorphisms in determining lipid
metabolism.
Current dietary guidelines for fat intake have not taken into
consideration the possible genetic differences underlying the
individual variability in responsiveness to dietary components.
Genetic variability has been identified in humans for all the
known lipid metabolim-related genes resulting in a plethora of
candidate genes and genetic variants to examine in diet-gene
interaction studies focused on fat consumption. Some
examples of fat-gene interaction are reviewed. These include:
the interaction between total intake and the 514C/T in the
hepatic lipase gene promoter in determining high-density
lipoprotein cholesterol (HDL-C) metabolism; the interaction
between polyunsaturated fatty acids (PUFA) and the 75G/A
polymorphism in the APOA1 gene plasma HDL-C
concentrations; the interaction between PUFA and the L162V
polymorphism in the PPARA gene in determining triglycerides
and APOC3 concentrations; and the interaction between
PUFA intake and the 1131TC in the APOA5 gene in
determining triglyceride metabolism. Although hundreds of
diet-gene interaction studies in lipid metabolism have been
published, the level of evidence to make specific nutritional
recommendations to the population is still low and more
research in nutrigenetics has to be undertaken.
KEY-WORDS: Diet – Genes – Interaction – Lipids –
Nutrigenetics – Polymorphisms.
1. INTRODUCTION
Currently, there is a lot of controversy about
which is the best diet to prevent or treat disease
(Steinberg D, 2005; Getz et al., 2007; Rioux et al.,
2007). Cardiovascular diseases are the leading
cause of death in the World whether living in rich 
or in poor countries. The implication of plasma lipids
in the atherosclerotic process that determines 
cardiovascular diseases has been known for many
years (Le and Walter, 2007). However, lipid
metabolism is a complex process in which different
enzymes, receptors, transporters, lipoproteins, etc.,
are involved. Thus, from food intake to the plasma
lipid concentrations detected, a great number of
steps take place, than can differ considerably among
individuals. It is therefore not surprising that many
studies have been carried out with differing results
when the relationship between diet and plasma
lipids has been investigated (Katan, 2005; Brunner
et al., 2007). Arising from this controversy several
eating pyramids have been proposed: The healthy
eating pyramid, the Mediterranean diet pyramid, the
United States Department of Agriculture (USDA)
pyramid, the World Health Organization (WHO) 
pyramid, etc (Chiuve and Willet, 2007). For several
decades, the debate on diet and lipid metabolism
and cardiovascular diseases has been dominated
by the classic “diet-heart” hypothesis centered in 
the concept of the promotion of a low-fat diet 
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in preventing the adverse effect of dietary saturated
fatty acids (SFA) and cholesterol on cardiovascular
risk. Therefore, reduction of fat intake has been the
main focus of national and international public health
recommendations for risk reduction. However, this
approach has been increasingly criticized for being
too simplistic. Moreover, the studies on which
current nutritional recommendations are based, 
were conducted without taking into account
possible genetic differences in response. However,
in a normal situation, there is a variability in 
the individual responses following a dietary
intervention to decrease total cholesterol
concentrations or to decrease other plasma lipid
parameters. Depending on their response,
individuals are called: hypo-responders, normo-
responders or hyper-responders. As an example
of inter-individual variations in the change in lipid
profile as a response to the same diet we have the
paper of Schaefer et al. (1997) in which, after
intervention with the National Cholesterol
Education Program Step 2 diet, a wide variability
in plasma low-density lipoprotein cholesterol (LDL-
C), high-density lipoprotein cholesterol (HDL-C)
and triglyceride (TG) concentrations in response
to diet was observed. Can individual differences in
diet response be explained by variations in the
genome? If we assume diet-gene interaction, can
nutritional recommendations in lipid metabolism
be made regardless of genes? To answer these
questions, much more research has to be
undertaken on diet-gene interaction. Hence, there
is a need to know which specific genetic variations
are those that modify the effects of diet on lipid
metabolism and the risk of disease. We have to
investigate: which genes are relevant; how many
variations in each gene must be studied and which
specific dietary components are interacting with
each genetic variation to determining the specific
phenotype.
In the last few years a new discipline has
emerged: Nutrigenetics. It examines the effect of
genetic variation on the interaction between diet and
disease. This includes identifying gene variants
associated with differential responses to nutrients.
Thus, the goal of nutrigenetics is to generate
recommendations regarding the risks and benefits of
specific diets or dietary components for the individual.
It has also been termed personalized nutrition or
individualized nutrition (Ordovas and Corella, 2004).
Although the initial studies have focused on single
nucleotide polymorphisms (SNP) to measure DNA
variation (genotypic or haplotypic approaches), in the
last few years, new types of DNA variation such as
copy number variation, are increasing in interest
(Rodriguez-Revenga et al, 2007).
2. SOME EXAMPLES OF FAT-GENE
INTERACTIONS IN DETERMINING LIPID
METABOLISM
Dietary fats have been the component of the diet
that has been more studied in nutrigenetic studies.
There are hundred of papers that report the
presence of a statistically significant interaction
between dietary fatty acids and different SNP in
candidate genes in determining plasma lipid
concentrations. In an excellent systematic review
(from 1966 to 2002), Masson et al. (2003) identified
74 relevant  articles on dietary intervention studies
that had measured the lipid and lipoprotein
response to dietary intervention in different
genotype groups and 17 reviews on gene-diet
interactions. They analyzed the published articles
according to seven groups of genetic locus:
Apolipoprotein (apo) A-I, C-III, and A-IV cluster;
ApoB; ApoE; Enzymes (lipoprotein lipase, hepatic
lipase, and cholesterol- 7-hydroxylase); LDL-
receptor gene; and other genes, including CETP,
fatty-acid-binding protein (FABP), and neuropeptide
Y (NPY). At each locus, one or more
polymorphisms were included, and the mainly
short-term response to a defined dietary
intervention [i.e., high-fat diet versus a low fat
diet; high-saturated fatty acids (SFA) versus high-
polyunsaturated fatty acids (PUFA); high-
monounsaturated fatty acids (MUFA) versus low-
MUFA, etc.]. After a comparative analysis of the
individual findings, Masson et al., (2003) conclude
that there is evidence to suggest that variations in
genes for apo A-I (APOA1), apo A-IV (APOA4), apo
B (APOB), and apo E (APOE) contributes to the
heterogeneity in the lipid response to dietary
intervention. However, the effects of the reported
gene-diet interactions are not consistently seen and
are sometimes conflicting. There are several
possible reasons to explain the discrepancies
between studies analyzing the modulation of the
lipid response to a similar dietary intervention by
the same polymorphism. One of them relates to the
small sample sizes used by most researchers,
which results in a lack of statistical power,
particularly for low allele frequencies. Another
important reason is the heterogeneity of the
subjects included in every study, differing in gender,
age, disease status, medical treatment, etc. In
addition, the length and the composition of the
dietary treatment greatly vary between studies.
Therefore, for future work it is necessary to
standardize a minimum set of variables to be
considered in the design of intervention studies in
order to replicate into the same conditions that
assure a good comparison in results of different
studies.
As more detailed studies, various examples 
of fat-gene interactions in determining lipid
metabolism that we have described over recent
years, are presented.
2.1. Hepatic lipase gene variation and total 
fat intake in determining HDL-C
Hepatic lipase plays a major role in lipoprotein
metabolism as a lipolytic enzyme that hydrolyzes
triglycerides and phospholipids in chylomicron
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remnants, intermediate-density lipoproteins
(IDL), and HDL. Patients with hepatic lipase 
deficiency present with hypercholesterolemia or 
hypertriglyceridemia and accumulate -very 
low–density lipoproteins (VLDL), chylomicron
remnants, IDL, triglyceride-rich LDL, and HDLs.
Hepatic lipase is also an important determinant of
HDL concentration, converting the phospholipid-
rich HDL2 to HDL3 during reverse cholesterol
transport. Four common SNPs (–763A > G;
–710T > C; –514C > T and –250G > A) on the 
promoter of the hepatic lipase gene (LIPC), appear
to be in total linkage disequilibrium and define a
unique haplotype which has been demonstrated to
be functional. Ordovas et al., (2002) have found a
strong interaction between the –514C > T LIPC
polymorphism and dietary fat intake, and HDL-
related measures in 1020 men and 1110 women
participating in the Framingham Study. This gene-
nutrient interaction was highly significant and with a
strong dose-response effect in determining HDL-C
concentrations (P < 0.001), large HDL subfraction
(P < 0.001), and HDL size (P = 0.001) in both
men and women. Accordingly, the T allele was 
associated with significantly greater HDL-C
concentrations and particle size only in subjects
consuming < 30% of energy from fat. When total fat
intake was  30% of energy, mean HDL-C
concentrations and HDL-particle size were lowest
among those with the TT genotype, and no
differences were observed between CC and CT
individuals. This gene-diet interaction was further
examined in a multiethnic Asian population from
Singapore participating in the National Health
Survey carried out by the Ministry of Health. This
sample consisted of 1324 Chinese, 471 Malays and
375 Asian Indians (Tai et al., 2003).Tai et al., (2003)
found a highly significant interaction (P = 0.001)
between the –514C > T polymorphism in the LIPC
and total fat intake in determining TG concentration
and the HDL-C/TG ratio (P = 0.001) in the three
ethnic groups. Thus, TT subjects showed higher TG
concentrations only when fat intake was higher than
30% of total energy. This interaction also showed a
dose-response effect on triglyceride concentrations
depending on the amount of total fat consumed 
(P = 0.035). For HDL-C concentrations, the gene-
diet interaction was significant (P = 0.015) only in
subjects of Indian origin suggesting additional
mechanisms to be explored. Further studies carried
out in other populations have reported controversial
results. Thus, Zhang et al., (2005) in a study carried
out in 780 diabetic men participating in the Health
Professionals Follow-Up Study, described a
statistical significant interaction between the LIPC
polymorphism and fat intake. However the effects
were in the opposite direction. They found that
the association between the LIPC –514C-  T
polymorphism and plasma HDL-cholesterol
concentrations varied according to self-reported
intakes of total, saturated, monounsaturated, and
trans-fats. A significantly higher HDL-cholesterol 
concentration in relation to the T allele was confined
to men with higher intakes of total, saturated, or
monounsaturated fat. One of the limitations of this
study is the small sample size, taking into account
the low prevalence of subject with the TT genotype
in the White population (about 3.5 %).
On the other hand, Nettleton et al., (2007)
carried out a study in 11,806 (8897 Whites/
2909 African Americans) participating in the
Atherosclerosis Risk in Communities (ARIC)
study. This study consisted of a cohort of men and
women, aged 45-64, from four communities in the
United States (Forsyth County, North Carolina;
Jackson, Mississippi; Northwest Minneapolis
suburbs, Minnesota; Washington County, 
Maryland). They found that in Whites, the relation
between the LIPC polymorphism and HDL-C was
not modified by dietary fat intake. However, a
statistically significant interaction was found in
African Americans. In African Americans women,
when percent total fat intake was low, HDL-C
concentrations in CC subjects were approximately
5 mg/dL lower than in CT and TT subjects; however,
when percent total fat intake was high, HDL-C 
concentrations were similar between CC and 
TT homozygotes. Ethnic differences in gene 
expression or ethnic in dietary intake may be partly
responsible for these discordant findings. Moreover,
the –515C > T LIPC polymorphism may be in strong
linkage disequilibrium with another polymorphism in 
African Americans but not in Whites, therefore,
serving only as a marker of another causal
polymorphism. Ethnic differences in dietary
patterns and food selection may also complicate 
interpretation since it is likely that food sources of
fats and other nutrients differ between men and
women and between Whites, African Americans
and Asians, providing an additional set of potential
confounders.
2.2. PUFA interaction with PPARA, PPARG,
APOA1 and APOA5 gene variation
In the search for other food components that
could be susceptible to showing gene-diet
interactions we selected PUFA as they are
important modulators of gene expression. The
molecular mechanisms of PUFA regulation of gene
expression are still poorly understood, although
progress has been made in the last few years.
PUFA suppression of several hepatic genes was
shown to be due largely to a decrease in the rate of
gene transcription. Peroxisome proliferator-
activated receptors (PPARs) are transcription
factors that play a major role in regulating several
genes involved in lipid metabolism (Guri et al.,
2006). It has been shown that PUFA can modulate
the expression of these nuclear transcription
factors. PPAR-alpha (A) is a ligand-activated
transcriptional factor that belongs to the family of
nuclear receptors. PPARA regulates the expression
of genes involved in fatty acid beta-oxidation and is
a major regulator of energy homeostasis. Fibrates
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are PPARA agonists and have been used to treat
dyslipidemia for several decades because of their
TG lowering and HDL-C elevating effects. Several
common genetic variants in the PPARA have been
described. One of these polymorphisms, consisting
of a G484C transversion at the first base of codon
162, creates a missense mutation that alters
leucine to valine (L162V) and has functional
consequences on receptor activity. Interestingly, it 
was shown that the effect of the L162V 
polymorphism on the transcriptional activation
associated with ligand binding to PPARA depends
on the concentration of the ligand to which it is
exposed. A wide range of compounds were
identified as natural or synthetic ligands for PPARA.
Fatty acids, mainly PUFA and PUFA-derived
compounds, are natural ligands of PPARA (Jump,
2002). Thus, we hypothesized that dietary PUFA
can interact with the PPARA-L162V polymorphism
in determining the effects of this polymorphism on
plasma lipid concentrations. We carried out a diet-
gene interaction study in 1003 men and 1103
women who participated in the Framingham
Offspring cohort (Tai et al., 2005). PUFA intake
ranged from 2.0 to 16.5% of total energy intake in
men and from 1.2 to 13.7% of total energy intake in
women. The mean intake of dietary PUFA for the
whole population was ~ 6% of dietary energy. The
main source of PUFA was vegetable oil. We
considered together, as (n-3) fatty acids, the dietary
intake of -linolenic acid (ALA), eicosapentaenoic
acid (EPA), docosahexaenoic acid (DHA) and
docosapentaenoic acid. Linoleic acid (LA) and
arachidonic acid (AA) were grouped as (n-6) fatty
acids. LA was the most abundant PUFA in terms of
mass consumed and represented the basis for the
intake of the (n-6) fatty acid family, whereas AA
represented only 0.12 g/d of the total daily intake of
PUFA (n-6). To test the hypothesis that dietary
PUFA intake interacts with the PPARA L162V
polymorphism in determining plasma lipids, we first
examined total PUFA intake as a 2-category
variable according to the population mean (6% of
energy). After adjustment for covariates, significant
interaction terms were found only for TG (P = 0.037)
and apoC-III (P = 0.048) concentrations. When
PUFA intake was  6%, TG concentrations were
lower among those carrying the 162V allele (122 ±
7 mg/dL in l62V carriers vs. 136 ± 2 mg/dL in 162L
homozygotes). No significant decrease of TG
concentrations was found in LL homozygotes. The
interaction effect in determining plasma apoC-III
(Ooi et al., 2008) by PUFA category paralleled
similar results for TG. Taking into account that (n-3)
fatty acids are specifically indicated in the treatment
of hypertriglyceridemia (Kris-Etherton et al., 2002;
Bays et al., 2008), we examined the specific effect
for (n-6) and (n-3) dietary fatty acids on this gene-
diet interaction as 2-category variables, using the
population mean. Similar results were found for (n-
6) and (n-3) fatty acids. Although little is known
about the differential effect of (n-3) and (n-6) fatty
acids on the ligand-binding activity of PPARA and
specific transactivation in experimental studies, it is
thought that both (n-3) and (n-6) can regulate the
activity of PPARA. Further studies analyzing
polymorphisms in the PPARA (Chan et al., 2006) or
in the APOC3 (Olivieri et al., 2005) genes have
reported similar diet-gene interactions with dietary
PUFA in determining TG or apolipoprotein C-III
concentrations.
PPARgamma (PPARG) is another member of
the nuclear hormone receptor superfamily that
plays an important role in the differentiation of
adipocytes and in the regulation of insulin
sensitivity. Several PPARG isoforms have been 
identified. PPARG2 is expressed predominantly in
adipose tissue. The Pro12Ala polymorphism has
been widely studied with highly controversial
results. One of the most cited diet-gene interactions 
with the Pro12Ala polymorphism has been with
PUFA intake. Luan et al., (2001) reported an
interaction between the ratio of dietary PUFA to
SFA and this polymorphism on body mass index
(BMI) and fasting insulin. According to this
interaction, BMI was higher among carriers of the
Ala12 allele only when the PUFA/SFA ratio was low,
and the opposite effect was noted in the presence 
of higher PUFA/SFA ratios. The same was 
demonstrated for fasting insulin. However, when we
specifically tested this gene-nutrient interaction in
the Singaporean population consisting of 1,295
Chinese, 451 Malays, and 374 Indians (Tai et al.,
2004), we were not able to detect it. Our results are
in agreement with those of Robitaille et al., (2003),
who tested this specific interaction on BMI in the
Québec Family Study and found no statistical
significance. Moreover, their results were in the
opposite direction from those of Luan et al., (2001).
In the Framingham Study we also found 
that PUFA intake interacted with the –75G/A 
polymorphism in the APOA1 gene promoter in
determining HDL-C concentrations in women
(Ordovas et al., 2002). Thus, having established
three categories of PUFA intake (less than 4%, from
4 to 8% and higher than 8% of total energy), we
observed that the increase in PUFA intake only
reduced HDL-C concentrations in GG individuals.
However in carriers of the A allele, the HDL-C
increased as PUFA in the diet increased. The
separate effects of (n-6) and (n-3) fatty acids were
not specifically investigated in this study.
Also in the Framingham Study we described a
diet-gene interaction between PUFA intake and some
polymorphisms in the APOA5 gene in determining TG
metabolism (Lai et al., 2006). Apolipoprotein A5 is a
new member of the apolipoprotein gene family whose
initial discovery arose from comparative sequence
analysis of the mammalian APOA1/C3/A4 gene
cluster. Functional studies in mice suggested a
prominent role of APOA5 in TG concentrations. Mice
that overexpressed human APOA5 displayed 
significantly reduced TG, whereas mice that lacked
APOA5 had a large increase in plama TG
(Pennacchio et al., 2003). Sequencing of the APOA5
in humans has been performed in several studies to
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identify common polymorphisms for subsequent
genetic association studies. Several genetic variants
have been identified (Pennacchio et al., 2003; Kluger
et al., 2008). However, the most relevant are the
–1131T > C, and the a C-to-G nonsynonymous 
substitution (c. 56C > G) that changes codon 19 from
serine to tryptophan (S19W). These polymorphisms
are tag SNPs of two independent haplotypes. The
minor alleles of these polymorphisms have been
associated with higher TG concentrations in several
studies (Pennacchio et al., 2003). We analyzed
the effect of PUFA consumption on plasma TG
concentrations depending on the APOA5 
polymorphisms (Lai et al., 2006). After multivariate
control for potential confounders, a statistically
significant interaction (P < 0.001) between SNP
–1131T > C and PUFA intake (> 6% or < 6% of
energy) on TG concentration was found. The –1131C
allele was associated with an increase in fasting TG
(21%, P = 0.002) only in subjects consuming > 6% of
energy from PUFA. However, mean fasting TG
concentrations were not statistically higher in carriers
of the –1131C allele compared with the TT 
homozygotes when the PUFA consumption was low
(< 6%) (P = 0.600). We observed similar and 
significant interactions between PUFA consumption
and SNP –1131T > C on plasma remnant-likeparticles 
(RLP)-TG (P < 0.001) and RLP-C (P < 0.001).
As observed for fasting TGs, concentrations of RLP-
TG in subjects carrying the –1131C allele were
increased (P = 0.005) when they consumed more
than 6% of energy from PUFAs. When we analyzed
the interaction of SNP –1131T > C and PUFA intake
in determining LDL and VLDL sizes, we found
statistically significant interactions (P = 0.01 and P =
0.008, respectively). These were consistent with a
more atherogenic lipid profile in subjects carrying the
–1131C allele and consuming more than 6% of
energy from PUFAs. Thus, in carriers of the –1131C
allele, a high PUFA intake was associated with
smaller LDL particle size and also with larger VLDL
size. Using the same statistical models in which fat
intake was dichotomized according to its 
corresponding population mean, we did not uncover
any significant interactions between the APOA5
–1131T > C SNP and intake of total fat, SFAs, or 
MUFAs on concentrations of TG, RLP-TG, or RLP-C
or on LDL and VLDL particle size. This gene–diet
interaction also showed a clear dose-dependent
effect as well as a biologically plausible association
consistent with the expected metabolic pathways
involved. Moreover, the interaction observed for SNP
–1131T > C was not shared by SNP 56C > G, which
represents the other common haplotype. Because n-
3 and n-6 FAs may differ in their potential preventive
effect of hypertriglyceridemia (Le et al., 2007; Harris
et al., 2008) we further investigated whether the
PUFA-APOA5 interaction applied to the consumption 
of both families of PUFAs. Our results support the
notion that the above-reported interactions are
specific to (n-6) PUFA. The potentially negative
effects associated with elevated lipoprotein 
remnant concentrations observed in carriers of the 
APOA5 –1131C allele who consume high n-6 PUFA
were not observed for the consumption of n-3 PUFA.
3. FUTURE DIRECTIONS IN FAT-GENE
INTERACTIONS
There are many studies that have shown the
existence of common genetic polymorphisms with a
great impact on plasma lipid concentrations such as
APOE, APOA5, CETP, PPARA, etc. Moreover, there
are various studies that have shown statistical
significant diet-gene interactions between some of 
these polymorphism and different types of fat
from the diet of (total fat, PUFA, SFA, etc).
Although every day more and more studies are
undertaken, the level of evidence in nutrigenomics
is still too low to make nutritional recommendations
to the population. Thus, specifically-designed 
interventional as well as observational studies are
needed. In addition, new  bioinformatic  tools will be
necessary for exploiting and integrating data.
Although the current evidence from both
experimental and observational nutrigenetics
studies is not enough to start making specific
personalized nutritional recommendations of fat
intake based on genetic information, the
accumulated information is enticing now to show
proof of concept. Hence, in a few years the
“genomic” profile will be an important factor to 
optimize nutritional recommendations of fat intake
in lipid metabolism. An important development
comes from the transition of diet-gene interactions
from being a purely academic research activity, to
become an area of great attraction of food and
health-related industries, resulting from the 
potential of nutrigenetics of fat intake to become
one of the greatest developments for the prevention
of lipid-related disorders based on a more
personalized approach.
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